These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31010475)

  • 1. Urinary citrate: helpful to predict acid retention in CKD patients?
    Prot-Bertoye C; Vallet M; Houillier P
    Kidney Int; 2019 May; 95(5):1020-1022. PubMed ID: 31010475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring acid base status in CKD patients: can urinary citrate help?
    Prot-Bertoye C; Vallet M; Houillier P
    Kidney Int; 2021 Jan; 99(1):28-31. PubMed ID: 33390237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
    Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE
    Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eubicarbonatemic Hydrogen Ion Retention and CKD Progression.
    Madias NE
    Kidney Med; 2021; 3(4):596-606. PubMed ID: 34401727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of Covert Acid Stress in Patients with Chronic Kidney Disease: A Cross-Sectional Study.
    Goraya N; Madias NE; Mamun A; Simoni J; Wesson DE
    Am J Nephrol; 2022; 53(11-12):794-805. PubMed ID: 36642068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spot urinary citrate-to-creatinine ratio is a marker for acid-base status in chronic kidney disease.
    Gianella FG; Prado VE; Poindexter JR; Adams-Huet B; Li X; Miller RT; Sakhaee K; Maalouf NM; Moe OW
    Kidney Int; 2021 Jan; 99(1):208-217. PubMed ID: 32721446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidden Acid Retention with Normal Serum Bicarbonate Level in Chronic Kidney Disease.
    Koh ES
    Electrolyte Blood Press; 2023 Jun; 21(1):34-43. PubMed ID: 37434806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Acid-Base Balance in Patients With Chronic Kidney Disease.
    Nagami GT; Kraut JA
    Adv Chronic Kidney Dis; 2022 Jul; 29(4):337-342. PubMed ID: 36175071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A basic approach to CKD.
    Simon EE; Hamm LL
    Kidney Int; 2010 Apr; 77(7):567-9. PubMed ID: 20224583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retarding progression of chronic kidney disease: use of modalities that counter acid retention.
    Kraut JA; Madias NE
    Curr Opin Nephrol Hypertens; 2018 Mar; 27(2):94-101. PubMed ID: 29140821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Acidosis in CKD: Core Curriculum 2019.
    Raphael KL
    Am J Kidney Dis; 2019 Aug; 74(2):263-275. PubMed ID: 31036389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic acidosis in chronic kidney disease: mere consequence or also culprit?
    Kuhn C; Mohebbi N; Ritter A
    Pflugers Arch; 2024 Apr; 476(4):579-592. PubMed ID: 38279993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to the Treatment of Chronic Metabolic Acidosis in CKD.
    Raphael KL
    Am J Kidney Dis; 2016 Apr; 67(4):696-702. PubMed ID: 26776539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Acidosis of CKD: An Update.
    Kraut JA; Madias NE
    Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
    Harambat J; Kunzmann K; Azukaitis K; Bayazit AK; Canpolat N; Doyon A; Duzova A; Niemirska A; Sözeri B; Thurn-Valsassina D; Anarat A; Bessenay L; Candan C; Peco-Antic A; Yilmaz A; Tschumi S; Testa S; Jankauskiene A; Erdogan H; Rosales A; Alpay H; Lugani F; Arbeiter K; Mencarelli F; Kiyak A; Dönmez O; Drozdz D; Melk A; Querfeld U; Schaefer F;
    Kidney Int; 2017 Dec; 92(6):1507-1514. PubMed ID: 28729033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very Low-Protein Diet (VLPD) Reduces Metabolic Acidosis in Subjects with Chronic Kidney Disease: The "Nutritional Light Signal" of the Renal Acid Load.
    Di Iorio BR; Di Micco L; Marzocco S; De Simone E; De Blasio A; Sirico ML; Nardone L;
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28106712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does correction of metabolic acidosis slow chronic kidney disease progression?
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD.
    Raphael KL
    J Am Soc Nephrol; 2018 Feb; 29(2):376-382. PubMed ID: 29030467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid retention in chronic kidney disease is inversely related to GFR.
    Goraya N; Simoni J; Sager LN; Pruszynski J; Wesson DE
    Am J Physiol Renal Physiol; 2018 May; 314(5):F985-F991. PubMed ID: 29357423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic acidosis and the progression of chronic kidney disease.
    Chen W; Abramowitz MK
    BMC Nephrol; 2014 Apr; 15():55. PubMed ID: 24708763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.